An Ayurvedic Clinical study to evaluate the efficacy of different forms and doses of CURCUMIN for Rheumatoid Arthritis patients.

Not Applicable

Completed

• Conditions: RHEUMATOID ARTHRITIS PATIENTS

• Registration Number: CTRI/2018/01/011617
• Lead Sponsor: Plant Lipids P Limited

Brief Summary

A randomized, double blind, placebo controlled,four arm, parallel group study To evaluate the comparative efficacy of curcumin(low & high dose), white curcumin with that of a placebo

Detailed Description

Not available

Study Timeline

• Study Start: 2016-02-15
• Study Completion: 2016-12-20
• Last Update Posted: 2018-01-26

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• i.Patients with active RA for at least one (1) year, diagnosed according to the revised 1987 American College of Rheumatology (ACR) criteria for the classification of rheumatoid arthritis.
• ii.Receiving treatment on an outpatient basis.
• iii.Active disease at the time of screening.

Exclusion Criteria

Not provided

Study & Design

• Study Type: PMS
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the comparative efficacy of curcumin (low & high dose), white curcumin with that of a placebo	Screening – (Day - 7) | Baseline visit – (Day 0) | Visit 2 (Day 30) | Visit 3 (Day 60) | Visit 4 (Day 90)

Secondary Outcome Measures

Name	Time	Method
a.To assess the safety & tolerability of active products	b.To assess changes in various biomarkers during the study period among all the study group subjects.

Trial Locations

Locations (1)

DHANVANTARI AYURVEDA COLLEGE HOSPITAL AND RESEARCH CENTRE; 🇮🇳 Kannada, KARNATAKA, India

DHANVANTARI AYURVEDA COLLEGE HOSPITAL AND RESEARCH CENTRE

🇮🇳Kannada, KARNATAKA, India

Dr Prasanna S Mathad

Principal investigator

09448630289

prasannamathad@gmail.com